Knowles Appoints Laura Angelini to its Board of Directors
Knowles (NYSE: KN) has appointed Laura Angelini as an independent director to its Board of Directors. Angelini brings 30 years of experience in the medical device and healthcare industry, having served as General Manager of Renal Care Global Business Unit at Baxter International (2016-2021) and various leadership roles at Johnson & Johnson (1991-2016). She currently serves on the boards of DCC plc and Identiv, Inc.
The appointment aligns with Knowles' strategic transformation towards higher value markets and products. Angelini will also serve as a member of the Compensation Committee of Knowles' Board of Directors.
Knowles (NYSE: KN) ha nominato Laura Angelini come direttore indipendente del suo Consiglio di Amministrazione. Angelini porta con sé 30 anni di esperienza nel settore dei dispositivi medici e della sanità, avendo ricoperto il ruolo di Direttore Generale della Renal Care Global Business Unit presso Baxter International (2016-2021) e vari ruoli di leadership in Johnson & Johnson (1991-2016). Attualmente, fa parte dei consigli di amministrazione di DCC plc e Identiv, Inc.
Questa nomina è in linea con la trasformazione strategica di Knowles verso mercati e prodotti di maggior valore. Angelini servirà anche come membro del Comitato per la Retribuzione del Consiglio di Amministrazione di Knowles.
Knowles (NYSE: KN) ha nombrado a Laura Angelini como directora independiente en su Junta Directiva. Angelini aporta 30 años de experiencia en la industria de dispositivos médicos y atención médica, habiendo sido Directora General de la Unidad de Negocios Global de Cuidados Renales en Baxter International (2016-2021) y ocupando diversos roles de liderazgo en Johnson & Johnson (1991-2016). Actualmente, forma parte de los consejos de DCC plc e Identiv, Inc.
La designación está en línea con la transformación estratégica de Knowles hacia mercados y productos de mayor valor. Angelini también será miembro del Comité de Compensación de la Junta Directiva de Knowles.
Knowles (NYSE: KN)는 이사회에 독립 이사로 Laura Angelini를 임명했습니다. Angelini는 Baxter International의 신장 관리 글로벌 사업부의 총괄 관리자(2016-2021)와 Johnson & Johnson(1991-2016)에서 다양한 리더십 역할을 맡으며 30년의 경험을 보유하고 있습니다. 현재 그녀는 DCC plc 및 Identiv, Inc. 이사로 활동하고 있습니다.
이번 임명은 Knowles가 더욱 가치 있는 시장과 제품으로 전략적으로 전환하고 있는 것과 일치합니다. Angelini는 Knowles 이사회의 보상위원회의 위원으로도 활동할 것입니다.
Knowles (NYSE: KN) a nommé Laura Angelini en tant que directrice indépendante de son Conseil d'Administration. Angelini apporte avec elle 30 ans d'expérience dans l'industrie des dispositifs médicaux et de la santé, ayant été Directrice Générale de l'Unité Commerciale Mondiale des Soins Rénaux chez Baxter International (2016-2021) et ayant occupé divers postes de leadership chez Johnson & Johnson (1991-2016). Actuellement, elle siège aux conseils d'administration de DCC plc et d'Identiv, Inc.
Cette nomination s'inscrit dans la transformation stratégique de Knowles vers des marchés et des produits de plus grande valeur. Angelini sera également membre du Comité de Rémunération du Conseil d'Administration de Knowles.
Knowles (NYSE: KN) hat Laura Angelini als unabhängige Direktorin in seinen Vorstand berufen. Angelini bringt 30 Jahre Erfahrung in der Medizintechnik- und Gesundheitsbranche mit, nachdem sie von 2016 bis 2021 als Generalmanagerin der Renal Care Global Business Unit bei Baxter International tätig war und verschiedene Führungspositionen bei Johnson & Johnson (1991-2016) innehatte. Derzeit ist sie in den Vorständen von DCC plc und Identiv, Inc. tätig.
Die Ernennung steht im Einklang mit der strategischen Transformation von Knowles hin zu wertvolleren Märkten und Produkten. Angelini wird auch Mitglied des Entschädigungsausschusses des Vorstands von Knowles sein.
- Strategic appointment strengthens board expertise in medical device and healthcare sectors
- Adds valuable experience in global strategic marketing and business development
- Supports company's transformation towards higher-value markets
- None.
Ms. Angelini has 30 years of experience in the medical device and healthcare industry. She most recently served as General Manager of the Renal Care Global Business Unit at Baxter International Inc., from 2016 to 2021. Prior to that, Ms. Angelini served in various roles at Johnson & Johnson from 1991 to 2016, including as President of
“We are delighted to welcome Laura to Knowles’ Board of Directors. Her extensive executive, global and strategic marketing experience with large, multinational manufacturing companies in the medical device industry and her insights into the healthcare and medical markets will benefit Knowles as we continue the Company’s strategic transformation to focus on higher value markets and products and to enhance shareholder value,” said Don Macleod, chairman of the board of Knowles.
Ms. Angelini will also serve as a member of the Compensation Committee of Knowles’ Board of Directors.
About Knowles
Knowles is a market leader and global provider of high-performance capacitors and radio frequency ("RF") filtering products, and advanced micro-acoustic microphones and balanced armature speakers, serving the medtech, defense, electric vehicle, and industrial markets. Knowles' focus on the customer, combined with unique technology, proprietary manufacturing techniques, and global operational expertise, enables us to deliver innovative solutions across multiple applications. Founded in 1946 and headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241209397976/en/
Sarah Cook
Knowles Investor Relations
Email: investorrelations@knowles.com
Source: Knowles Corporation
FAQ
Who is the new board member appointed to Knowles (KN)?
What is Laura Angelini's experience before joining Knowles (KN) board?
What committee will Laura Angelini serve on at Knowles (KN)?
How does Laura Angelini's appointment align with Knowles (KN) strategy?
